Ebola treatment developed from horse antibodies
08 February, 2017Antibodies sourced from horses could be used as part of post-exposure treatment in the next Ebola outbreak, according to an international research team.
Accelerated HIV reduction in animal trial
07 February, 2017Biotron has completed its HIV-1 animal trial of drug candidate BIT225, announcing positive results which caused the company's share prices to rise by almost 15%.
Fibrosis drug inspired by a shark antibody
01 February, 2017Scientists from La Trobe University and biotechnology company AdAlta have created a humanised version of an antibody found in Wobbegong sharks.
Bioprinted kidneys
25 January, 2017 by Adam FloranceA collaborative effort between the Murdoch Childrens Research Institute, the Methuselah Foundation and Organovo has created a new hope for children suffering from kidney disease, with a pioneering use of 3D bioprinting technology.
The needle that makes brain surgery safer
23 January, 2017Researchers have developed a brain biopsy needle with a tiny imaging probe inside, enabling surgeons to 'see' and avoid at-risk blood vessels as they insert the needle into patients' brains.
Lonza to acquire capsule manufacturer Capsugel
21 December, 2016Lonza Group has entered into a definitive agreement to acquire drug capsule manufacturer Capsugel from the latter's parent organisation, KKR.
Add-on asthma treatments now available through the PBS
20 December, 2016The Turnbull government will invest close to $130 million to give Australian asthma sufferers subsidised access to breakthrough medicines through the Pharmaceutical Benefits Scheme (PBS).
The golden touch: light-activated nanoparticles to treat macular degeneration
19 December, 2016For sufferers of age-related macular degeneration (AMD), the only way to prevent severe vision loss is to endure regular injections into the back of the eye.
Biomedical Translation Fund managers announced
13 December, 2016The Turnbull government has selected the three venture capital fund managers who will manage the Biomedical Translation Fund (BTF), intended to help take Australian biomedical discoveries out of the laboratory and to the patient.
White blood cells at the ready for chemo patients
06 December, 2016University of Queensland (UQ) researchers have developed a way to produce and administer white blood cells to cancer patients following chemotherapy.
CWE SAR-1000 small animal ventilator
06 December, 2016The SAR-1000 is CWE's ventilator for mice, rats and other small animals for in vivo research, preclinical drug development, surgery and long-duration studies.
New drug to prevent food allergies
28 November, 2016Nobel Laureate Barry Marshall is developing a drug that restores balance to the immune system to help desensitise allergic responses to foods such as peanuts and shellfish.
Clinical trial of Alzheimer's drug fails
25 November, 2016 by Lauren DavisEli Lilly regrettably announced this week that a clinical trial of its key Alzheimer's drug, solanezumab, has failed to meet the primary endpoint.
River blindness vaccine to begin trials
23 November, 2016A vaccine with the potential to prevent millions of cases of blindness is one step closer to commercialisation, with trials in cattle set to commence before the end of the year.
QuickFire Challenge winners look to solve global health issues
21 November, 2016The World Without Disease QuickFire Challenge was a global competition that sought comprehensive, end-to-end, integrated solutions that have the potential to improve the health of people around the world.
